Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Coats’ disease with macular oedema responsive to aflibercept and argon laser
Journal Information
Vol. 92. Issue 7.
Pages 330-333 (July 2017)
Share
Share
Download PDF
More article options
ePub
Visits
21
Vol. 92. Issue 7.
Pages 330-333 (July 2017)
Short communication
Coats’ disease with macular oedema responsive to aflibercept and argon laser
Enfermedad de Coats con edema macular sensible al aflibercept y láser argón
Visits
...
M.C. Guixeres Esteve
Corresponding author
mariaguixeres@gmail.com

Corresponding author.
, A.O. Pardo Saiz
Servicio de Oftalmología, Hospital Dr. Peset, Valencia, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Abstract
Clinical case

A 14 year-old boy with Coats’ disease in his right eye, presented with a visual acuity (VA) of 0.1, micro-aneurysms, exudates, a macular oedema of 959 microns, and peripheral telangiectasias. After 12 months follow-up with 6 ranibizumab injections and 3 sessions of argon laser photocoagulation, the macular oedema remained and VA was 0.2. Following 4 aflibercept injections and another 2 laser sessions, he had a good foveal slope and a VA of 0.5, with no recurrences in the last 12 months.

Discussion

Treatment with aflibercept and argon laser was effective in our patient with stage 2B Coats’ disease and macular oedema unresponsive to ranibizumab.

Keywords:
Coats’ disease
Argon laser
Ranibizumab
Aflibercept
Resumen
Caso clínico

Varón de 14 años con enfermedad de Coats en su ojo derecho. Agudeza visual (AV) 0,1. Microaneurismas, exudados, edema macular de 959μm y telangiectasias periféricas. Tras 12 meses iniciales con 6 inyecciones de ranibizumab y 3 sesiones de láser argón, persistía edema macular de 553μm y AV 0,2. Después de 4 dosis de aflibercept y otras 2 sesiones de láser, presenta buen perfil foveal y AV 0,5, sin recurrencias desde hace 12 meses.

Discusión

El tratamiento con aflibercept combinado con láser argón, resultó efectivo en nuestro paciente con enfermedad de Coats en estadio 2B y edema macular, con respuesta incompleta al ranibizumab.

Palabras clave:
Enfermedad de Coats
Láser argón
Ranibizumab
Aflibercept

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos